Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity

Patient Income Level and Cancer Clinical Trial Participation

(2016) Joseph M. Unger et al.   JAMA Oncology

Cross-over—it's a feature, not a bug: Figure 1.

(2015) A. Engelsberg   ANNALS OF ONCOLOGY

Oncology 2020: a drug development and approval paradigm

(2015) K. Dhingra   ANNALS OF ONCOLOGY

The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in asthma

(2015) Ashley Woodcock et al.   BMC Pulmonary Medicine

Expediting Drug Development — The FDA's New “Breakthrough Therapy” Designation

(2013) Rachel E. Sherman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Methodological Standards and Patient-Centeredness in Comparative Effectiveness Research

(2012)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Prospective Analysis of the Influence of Older Age on Physician and Patient Decision-Making When Considering Enrollment in Breast Cancer Clinical Trials (SWOG S0316)

(2012) S. H. Javid et al.   ONCOLOGIST

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

(2008) Jesús F. San Miguel et al.   NEW ENGLAND JOURNAL OF MEDICINE